Agios Pharmaceuticals, Inc.
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.8 | 2.8 | 2.5 | 3.0 | – | – | – | – | |
| 38.1 | 25.1 | 50.3 | 45.0 | 58.0 | 64.9 | 110.4 | 69.1 | 60.3 | 28.4 | 34.0 | 28.8 | 16.9 | 25.9 | 13.9 | 19.8 | 12.4 | 14.8 | 22.8 | 21.4 | 21.5 | 22.7 | 41.6 | 189.7 | 156.3 | 108.1 | 66.8 | 78.1 | 57.6 | 46.5 | 56.0 | 78.2 | 78.9 | 51.5 | 45.5 | 47.2 | 52.1 | 29.4 | 30.1 | 22.4 | |
| 5.1 | 4.9 | 8.0 | 4.7 | 7.2 | 7.4 | 5.3 | 5.9 | 5.9 | 3.9 | 6.4 | 5.5 | 4.2 | 4.8 | 3.9 | 6.6 | 5.0 | 7.5 | 1.6 | 2.0 | 1.9 | 1.4 | 1.3 | 1.1 | 1.5 | 1.4 | 1.2 | 1.6 | 1.6 | 1.5 | 2.2 | 3.7 | 1.6 | 1.2 | 1.1 | 1.4 | 1.8 | 1.3 | 1.8 | 2.2 | |
| 32.7 | 19.1 | 46.2 | 42.4 | 55.6 | 54.6 | 88.3 | – | – | 20.5 | 33.8 | 28.1 | 16.3 | 25.3 | 13.5 | 18.3 | 11.9 | 14.2 | 10.8 | 15.3 | 18.3 | 20.3 | 39.8 | 177.8 | 145.3 | 99.3 | 62.1 | 74.6 | 55.5 | 43.7 | 52.5 | 76.0 | 71.7 | 49.9 | 43.8 | 45.6 | 50.4 | 28.1 | 28.6 | 21.6 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.2 | 2.5 | 2.3 | 2.7 | – | – | – | – | |
| 42.1 | 61.3 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 2.4% | 1.6% | -1.0% | -9.9% | -8.2% | -10.4% | -6.9% | -6.7% | -7.0% | -11.6% | -8.0% | -11.5% | -18.8% | -12.5% | -15.9% | -10.0% | -14.7% | -10.2% | -8.8% | -10.8% | -14.2% | -23.1% | -24.7% | -28.8% | -21.7% | -20.4% | -24.3% | -19.1% | -21.0% | -23.8% | -18.3% | -12.6% | -12.7% | -20.8% | -24.0% | -21.2% | -17.8% | -23.8% | -19.4% | -16.5% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| -259.9% | -215.0% | -386.3% | -400.8% | -401.5% | -580.5% | -646.8% | -348.0% | -227.4% | -76.2% | 23.6% | 98.0% | 98.5% | 98.9% | 99.1% | 99.0% | 98.9% | 98.6% | 69.2% | 42.9% | 23.5% | -23.8% | -47.9% | -206.4% | -102.2% | -42.3% | -5.0% | -0.9% | 33.6% | 51.0% | 65.4% | 75.5% | 76.2% | 80.5% | 79.8% | 82.0% | 78.5% | 78.7% | 82.1% | 87.9% | |
| -345.1% | -287.6% | -497.6% | -509.6% | -515.7% | -745.8% | -842.7% | -477.9% | -480.3% | -384.0% | -315.9% | -400.2% | -370.5% | -361.6% | -212.9% | -187.4% | -169.4% | -155.6% | -231.2% | -231.9% | -298.1% | -480.5% | -1,017.2% | -6,154.7% | -3,974.8% | -2,732.1% | -1,990.4% | -1,859.2% | -1,599.6% | -1,459.5% | -1,336.4% | -1,293.9% | -1,238.1% | -1,166.5% | -1,188.9% | -1,129.1% | -1,061.8% | -873.9% | -720.0% | -466.8% | |
| -341.6% | -284.0% | -491.5% | -502.1% | -506.4% | -731.6% | -822.3% | -462.1% | -461.8% | -366.6% | -300.6% | -383.1% | -356.4% | -349.0% | -205.2% | -182.5% | -170.6% | -161.1% | -257.3% | -252.9% | -315.5% | -488.1% | -945.5% | -5,758.5% | -3,655.1% | -1,627.8% | -1,146.6% | -1,042.6% | -913.9% | -1,312.6% | -1,199.3% | -1,165.7% | 2,051.4% | 1,845.9% | 1,798.3% | 1,590.4% | -895.9% | -764.0% | -639.8% | -418.2% | |
| 90.5% | 41.0% | -49.2% | -447.4% | -477.2% | -673.9% | -765.6% | -461.6% | -420.5% | -329.9% | -273.0% | -331.5% | -317.9% | -324.6% | -221.4% | -198.8% | -182.6% | -150.0% | -201.3% | -230.3% | -304.9% | -524.5% | -1,026.3% | -5,463.8% | -3,390.5% | -2,207.6% | -1,627.0% | -1,489.0% | -1,209.4% | -1,107.5% | -1,025.4% | -982.2% | -1,004.3% | -1,072.7% | -1,090.2% | -1,000.7% | -924.5% | -698.3% | -582.5% | -371.4% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -45.5% | -55.3% | -78.5% | -52.8% | -62.9% | -83.8% | -39.2% | -39.5% | -45.1% | -50.3% | -56.2% | -73.1% | -89.4% | -64.2% | -57.4% | -60.7% | -69.1% | -81.9% | -17.6% | -23.1% | -27.8% | -29.8% | -29.9% | -32.9% | -34.6% | -21.1% | -21.0% | -21.8% | -24.8% | -43.4% | -47.4% | -55.2% | 41.5% | 43.7% | 45.4% | 47.5% | -31.2% | -34.6% | -38.1% | -40.1% | |
| -27.2% | -32.1% | -43.3% | -35.3% | -41.2% | -51.2% | -32.6% | -32.6% | -36.9% | -40.3% | -42.4% | -49.7% | -57.4% | -46.2% | -44.8% | -34.8% | -36.6% | -38.4% | -16.3% | -21.2% | -25.1% | -26.7% | -27.0% | -29.5% | -30.8% | -18.7% | -18.9% | -19.4% | -21.8% | -37.6% | -41.5% | -47.2% | 37.6% | 40.5% | 42.8% | 44.2% | -29.0% | -31.8% | -35.7% | -37.1% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -286 | -419 | -200 | -139 | -133 | -442 | -913 | – | – | -746 | -28 | -77 | -74 | -74 | -82 | -289 | -98 | -120 | -1,880 | -959 | -390 | -192 | -68 | -76 | -109 | -126 | -90 | -70 | -50 | -73 | -103 | -69 | -237 | -59 | -62 | -63 | -75 | -71 | -95 | -80 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -0.3 | -0.1 | -0.1 | -0.1 | – | – | – | – | |
| 59.7% | 57.9% | 55.2% | 66.9% | 65.5% | 61.1% | 83.2% | 82.5% | 81.8% | 80.1% | 75.4% | 68.0% | 64.2% | 71.9% | 78.2% | 57.2% | 52.9% | 46.8% | 92.3% | 91.8% | 90.5% | 89.9% | 90.4% | 89.7% | 89.0% | 88.9% | 90.0% | 88.9% | 88.0% | 86.5% | 87.6% | 85.4% | 90.8% | 92.7% | 94.3% | 93.1% | 92.7% | 92.0% | 93.6% | 92.6% | |
| 0.0 | 0.4 | 0.0 | 0.0 | 0.0 | 0.3 | 0.1 | – | – | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -4.74 | -4.71 | -5.71 | -5.75 | -5.84 | -6.45 | -6.09 | -5.63 | -5.90 | -5.95 | -5.96 | -6.63 | -6.82 | -6.43 | -5.23 | -4.92 | -4.80 | -4.73 | -5.83 | -6.52 | -6.79 | -7.07 | -6.62 | -6.74 | -6.62 | -4.23 | -3.95 | -3.78 | -3.94 | -6.30 | -6.25 | -6.42 | 11.54 | 11.79 | 11.59 | 11.22 | -6.90 | -7.08 | -7.19 | -6.91 | |
| 1.39 | 1.66 | 1.16 | 1.14 | 1.15 | 0.88 | 0.74 | 1.22 | 1.28 | 1.62 | 1.98 | 1.73 | 1.91 | 1.84 | 2.55 | 2.70 | 2.81 | 2.93 | 2.26 | 2.58 | 2.15 | 1.45 | 0.70 | 0.12 | 0.18 | 0.26 | 0.34 | 0.36 | 0.43 | 0.48 | 0.52 | 0.55 | 0.56 | 0.64 | 0.64 | 0.71 | 0.77 | 0.93 | 1.12 | 1.65 | |
| 10.41 | 8.52 | 7.27 | 10.89 | 9.28 | 7.70 | 15.54 | 14.26 | 13.10 | 11.82 | 10.61 | 9.07 | 7.62 | 10.02 | 9.11 | 8.10 | 6.95 | 5.77 | 33.02 | 28.20 | 24.45 | 23.78 | 22.13 | 20.51 | 19.15 | 20.09 | 18.76 | 17.34 | 15.89 | 14.51 | 13.19 | 11.63 | 27.84 | 26.96 | 25.52 | 23.64 | 22.09 | 20.45 | 18.87 | 17.25 | |
| 1.25 | 0.68 | -0.57 | -5.12 | -5.50 | -5.94 | -5.67 | -5.62 | -5.37 | -5.35 | -5.41 | -5.74 | -6.08 | -5.99 | -5.64 | -5.36 | -5.14 | -4.40 | -4.56 | -5.94 | -6.56 | -7.60 | -7.18 | -6.40 | -6.14 | -5.74 | -5.60 | -5.40 | -5.21 | -5.31 | -5.35 | -5.41 | -5.65 | -6.85 | -7.03 | -7.06 | -7.12 | -6.47 | -6.54 | -6.14 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.